Cargando…
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
One of the hallmarks of cancer is its unlimited replicative potential that needs a compensatory mechanism for the consequential telomere erosion. Telomerase promoter (TERTp) mutations were recently reported as a novel mechanism for telomerase re-activation/expression in order to maintain telomere le...
Autores principales: | Vinagre, João, Nabais, Joana, Pinheiro, Jorge, Batista, Rui, Oliveira, Rui Caetano, Gonçalves, António Pedro, Pestana, Ana, Reis, Marta, Mesquita, Bárbara, Pinto, Vasco, Lyra, Joana, Cipriano, Maria Augusta, Ferreira, Miguel Godinho, Lopes, José Manuel, Sobrinho-Simões, Manuel, Soares, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944231/ https://www.ncbi.nlm.nih.gov/pubmed/27411289 http://dx.doi.org/10.1038/srep29714 |
Ejemplares similares
-
Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours
por: Pestana, Ana, et al.
Publicado: (2020) -
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
por: Batista, Rui, et al.
Publicado: (2020) -
Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas
por: Ropio, Joana, et al.
Publicado: (2023) -
Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
por: Gaspar, Tiago Bordeira, et al.
Publicado: (2022) -
Hereditary Tumours
por: Baudi, Francesco
Publicado: (2013)